Form 4: Clorox Director Boosts Stake with Deferred Stock Units
Insider Transaction Report
Clorox Director Julia Charter increased her beneficial ownership of the company's common stock equivalents through several deferred stock unit acquisitions in 2025.
Summary
- Julia Charter, a Director of The Clorox Company (CLX), reported multiple acquisitions of Deferred Stock Units during 2025.
- These acquisitions include units obtained through dividend reinvestment under the Independent Directors' Deferred Compensation Plan on four separate dates.
- An annual award of Deferred Stock Units was also received on December 31, 2025, pursuant to the 2005 Stock Incentive Plan.
- The Deferred Stock Units will be settled on a 1-for-1 basis in Clorox common stock upon Ms. Charter's retirement or other termination of service as a Director.
- Following these transactions, Ms. Charter beneficially owns a total of 4,471.9997 Deferred Stock Units.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a director's increased beneficial ownership through deferred stock units aligns their interests with shareholders, indicating confidence in the company's long-term performance. These are routine, non-cash compensation events.
Positives
- Increased beneficial ownership by a director aligns management interests with those of shareholders.
- The acquisitions are part of established compensation and dividend reinvestment plans, indicating routine and planned insider activity.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholders due to higher beneficial ownership, potentially fostering greater confidence in governance and long-term strategy.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Acquisition of 22.4752 Deferred Stock Units through dividend reinvestment. |
| 05/09/2025 | Acquisition of 24.8735 Deferred Stock Units through dividend reinvestment. |
| 08/29/2025 | Acquisition of 29.0841 Deferred Stock Units through dividend reinvestment. |
| 11/06/2025 | Acquisition of 32.6854 Deferred Stock Units through dividend reinvestment. |
| 12/31/2025 | Annual award of 1,637.8577 Deferred Stock Units. |
| 01/05/2026 | Date the Form 4 filing was signed and submitted. |
Recommendation
holdThis Form 4 filing details routine acquisitions of deferred stock units by a director as part of compensation and dividend reinvestment plans. While it indicates continued insider alignment and confidence, these transactions do not provide new fundamental information or a significant shift in company prospects that would warrant a change in an existing investment thesis. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Clorox, CLX, Insider Transaction, Form 4, Deferred Stock Units, Director Compensation, Equity Ownership, Dividend Reinvestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.